Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Tanabe presents water-soluble taxane with better activity than paclitaxel and docetaxel

Nov. 25, 1998

MGI Pharma initiates phase II study of MGI-114 in pancreatic cancer patients

Nov. 25, 1998

New agents for glioblastoma in preclinical testing at Wayne Hughes Institute

Nov. 24, 1998

Acadia reaches milestone in Allergan collaboration and first clinical candidate is selected

Nov. 24, 1998

Mechanism of action of CI-958, a potential agent for prostate cancer in phase II trials

Nov. 24, 1998

Genta initiates another phase I/IIa prostate cancer trial with G-3139

Nov. 24, 1998

Gastrimmune enters phase III trials for pancreatic cancer

Nov. 20, 1998

Parke-Davis identifies potent inhibitor of PDGF receptor TK and PDGF-dependent tumor growth

Nov. 20, 1998

Antitumor tetramic acid compound produced by Streptomyces

Nov. 20, 1998

Clarion prepares novel compounds for cancer, psoriasis and inflammation

Nov. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.